Post-op pain Outcome after monosegmental Spinal microdistectomy
Conditions
Interventions
Trade Name: Hypericum perforatum C200
Product Name: Hypericum perforatum C 200
Product Code: 2502726
Pharmaceutical Form: Pillules
Pharmaceutical form of the placebo: Pessary
Route of administration o
Sponsors
Witten-Herdecke University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: monosegmental spinal microdistectomy the day before Age between 18 and 75 Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 100 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 100
Exclusion criteria
Exclusion criteria: somatic pain desease sedic medication psycosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Post-op pain measured on a 100 mm VAS on the 3rd day postOP;Secondary Objective: postOP use of analgetic medication;Primary end point(s): Post-op pain reduction measured on a 100 mm VAS on the 3rd day postOP compared to baseline;Timepoint(s) of evaluation of this end point: 3rd day postOP | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): reduction of postOP use of analgetic medication;Timepoint(s) of evaluation of this end point: 5th day postOP | — |
Countries
Germany
Contacts
Public ContactInstitute for Integrative Medicine
Witten-Herdecke University
Outcome results
None listed